Tata India Pharma & Healthcare Fund Growth
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation20.3%
Sharpe Ratio0.47
Beta1.05
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices11.17%
Cash / Net Current AssetUtilities7.36%
Apollo Hospitals Enterprise LtdServices7.19%
Cipla LtdServices5.76%
Divi's Laboratories LtdServices5.58%
Aurobindo Pharma LtdServices5.44%
Fortis Healthcare LtdServices5.30%
Lupin LtdServices4.58%
Aster DM Healthcare Ltd Ordinary SharesServices4.45%
Wockhardt LtdServices3.67%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.11%
Exit Load0.25
Regulatory & Tax Information
INF277K016A9
ISINDailyDealing Frequency
BSE Healthcare PRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)